Ma, Y. et al. Interleukin-10 counteracts T-helper type 1 responses in B-cell lymphoma and is a target for tumor immunotherapy. Cancer Lett. 503, 110-116 (2021)
Wang, H.X.* & Gires, O. Tumor-derived extracellular vesicles in breast cancer: From bench to bedside. Cancer Lett. 460, 54-64 (2019)
Halama, A.* et al. Accelerated lipid catabolism and autophagy are cancer survival mechanisms under inhibited glutaminolysis. Cancer Lett. 430, 133-147 (2018)
Rahn, S.* et al. Diabetes as risk factor for pancreatic cancer: Hyperglycemia promotes epithelial-mesenchymal-transition and stem cell properties in pancreatic ductal epithelial cells. Cancer Lett. 415, 129-150 (2018)
Hess J. et al. Genomic amplification of Fanconi anemia complementation group A (FancA) in head and neck squamous cell carcinoma (HNSCC): Cellular mechanisms of radioresistance and clinical relevance. Cancer Lett. 386, 87-99 (2017)
Schilling, D. ; Garrido, C.* ; Combs, S.E. & Multhoff, G. The Hsp70 inhibiting peptide aptamer A17 potentiates radiosensitization of tumor cells by Hsp90 inhibition. Cancer Lett. 390, 146-152 (2017)
Berchtold, S.* et al. Collagen type V promotes the malignant phenotype of pancreatic ductal adenocarcinoma. Cancer Lett. 356, 721-732 (2015)
Multhoff, G. ; Pockley, A.G.* ; Schmid, T.E.* & Schilling, D.* The role of Heat shock protein 70 (Hsp70) in radiation-induced immunomodulation. Cancer Lett. 368, 179-184 (2015)
Rödel, F.* ; Frey, B.* ; Multhoff, G.* & Gaipl, U. Contribution of the immune system to bystander and non-targeted effects of ionizing radiation. Cancer Lett. 356, 105-113 (2015)
Schilling, D. et al. Sensitizing tumor cells to radiation by targeting the heat shock response. Cancer Lett. 360, 294-301 (2015)
Sokolenko, A.P.* et al. Identification of novel hereditary cancer genes by whole exome sequencing. Cancer Lett. 369, 274-288 (2015)
Hartmannsberger, D.* et al. Transketolase-like protein 1 confers resistance to serum withdrawal in vitro. Cancer Lett. 300, 20-29 (2011)
Mayer, C.* et al. A radiation-induced gene expression signature as a tool to predict acute radiotherapy-induced adverse side effects. Cancer Lett. 302, 20-28 (2011)
Allgeier, T. et al. Dendritic cell-based immunogens for B-cell chronic lymphocytic leukemia. Cancer Lett. 245, 275-283 (2007)
Münz, M. ; Zeidler, R.* & Gires, O. The tumour-associated antigen EpCAM upregulates the fatty acid binding protein E-FABP. Cancer Lett. 225, 151-157 (2005)
Eichholtz-Wirth, H. ; Fritz, E. & Wolz, L. Overexpression of the 'silencer of death domain', SODD/BAG-4, modulates both TNFR1- and CD95-dependent cell death pathways. Cancer Lett. 194, 81-89 (2003)
Pauli, C.* et al. Tumor-specific glycosylation of the carcinoma-associated epithelial cell adhesion molecule EpCAM in head and neck carcinomas. Cancer Lett. 193, 25-32 (2003)
Boffetta, P.* et al. O6-Alkylguanine-DNA-alkyltransferase activity in peripheral leukocytes, smoking and risk of lung cancer. Cancer Lett. 180, 33-39 (2002)
Oesterle, D. & Deml, E. Lack of initiating and promoting activity of thiourea in rat liver foci bioassay. Cancer Lett. 41, 245-249 (1988)